http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102266586-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_caf725a040f339540e8a5930f905afc0 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
filingDate | 2011-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd95c1032a661c9d045ad0d780f51d16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a69d48c08b99f1f36a710b0e5c1fb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25103d23b225798e6058bc453d25af73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5efeb751ae03339db62b09b4fd0bda17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd5718dc4b34b28ef242b34553b0626a |
publicationDate | 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102266586-B |
titleOfInvention | Preparation method of leucoderma melanocyte transplanting coating carrier system |
abstract | The invention relates to a preparation method of a leucoderma melanocyte transplanting coating carrier system. The method comprises the following steps of: preparing a melanocyte culture medium from a melanocyte basic culture solution Hams F12, fetal calf serum, a human granulocyte colony stimulating factor (G-CSF), a melanogenesis promoter, iso-methyl xanthine, adrenalin, a vitamin C mixed liquor and penicillin streptomycin for in-vitro culturing of autologous melanocytes; and constructing a coating carrier system by using Carbomer gel and the melanocyte culture medium. In the invention, the melanocyte culture medium containing the human G-CSF is used, so that massive in-vitro proliferation of melanocytes is realized; and the Carbomer gel plays a good role in fixing, so that the problem of easy loss of a cell suspension in the conventional melanocyte transplanting process is solved, the loss amount of melanocytes is reduced, the implantation rate is increased, damage to the melanocytes is avoided, the surgery cost is reduced, the preparation method is easy and safe for operating during clinical application, and a new way is provided for the treatment of leucoderma. |
priorityDate | 2011-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.